Outline

JEIM

Artificial Intelligence Driven Multi-Omics Integration for Prioritizing Genes Associated with Immune Dysfunction

Author(s): Alexander A. Morgan1, Vasilios J. Pyrgos2, Kari C. Nadeau3, Peter R. Williamson2, Atul Janardhan Butte1
1Biomedical Informatics Graduate Training Program and Division of Systems Medicine, Department of Pediatrics, Stanford University, Stanford, California, USA.
2Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
3Division of Immunology, Department of Pediatrics, Stanford University, Stanford, California, USA.
[mla_citation]

Abstract

Identification of genes responsible for immune dysfunction remains a major challenge in
genomic medicine. Previous studies have demonstrated that multiplex meta-analysis of
gene expression datasets can prioritize genes associated with immunodeficiency. However,
transcriptomic evidence alone may not fully capture the complex molecular mechanisms
underlying immune disorders. In this study, we propose an artificial intelligence driven
multi-omics framework that integrates transcriptomic meta-analysis, genomic variant information, and protein interaction networks to prioritize genes associated with immune
dysfunction. Machine learning algorithms are used to model nonlinear relationships between
heterogeneous biological datasets. The proposed framework improves gene prioritization
accuracy compared with traditional statistical approaches. This integrative strategy provides a scalable computational approach for identifying disease-associated genes and advancing precision medicine applications in immunology.

Keywords
Immunodeficiency; Multi-omics integration; Artificial intelligence; Gene prioritization; Precision medicine.

Related Articles

Azra Nishat1, Shazadi Sultana2, Arshiya Sultana2
1Department of Obstetrics and Gynecology, Government Nizamia Tibbi College Charminar, Hyderabad, India
2Department of Obstetrics and Gynecology, National Institute of Unani Medicine, PG Institute of Research, Bengaluru, Karnataka, India.
Rinaldo Bellomo1,2, John A. Kellum3, Claudio Ronco4
1Department of Intensive Care, Austin Hospital, Melbourne, Australia
2School of Medicine, The University of Melbourne, Australia
3Center for Critical Care Nephrology, University of Pittsburgh, USA.
4International Renal Research Institute, Vicenza, Italy.
Ivica Letunic1, Lars Nielsen1, Peer Bork2,3
1Biobyte solutions GmbH, Bothestr 142, 69126 Heidelberg, German
2EMBL, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
3Department of Bioinformatics, Biocenter, University of Würzburg, Würzburg, Germany.
Michael Henderson1, Carol Inatsuka2, Amanda J. Sheets1, Corinne L. Williams3, David J. Benaron2, Gina M. Donato4, Mary C. Gray4, Erik L. Hewlett4, Peggy A. Cotter1,3
1Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, USA.
2Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, USA.
3Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, USA
4Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, USA
Eisha Nisar1, Rong Chen2, Atul Janardhan Butte2
1Faisalabad Medical University, faisalabad, Pakistan.
2Lucile Packard Children’s Hospital, Palo Alto, California, USA.
Olusola Ayanniyi1, Olusoji G. Ige2
1Department of Physiotherapy, College of Medicine, University of Ibadan, Ibadan, Nigeria.
2Physiotherapy Department, College of Medicine, University of Ibadan/UCH, Ibadan, Nigeria.